Article Menu

Academic Editor

Carsten Stephan
Subscribe SciFeed
Recommended Articles
Related Info Links
- PubMed/Medline
- Google Scholar
More by Authors Links

/ajax/scifeed/subscribe

Article Views

Citations -

Printed Edition

A printed edition of this Special Issue is available at MDPI Books....

Altmetric Share Help Cite Discuss in SciProfiles

Need Help?

Support

Find support for a specific problem in the support section of our website.

Get Support

Feedback

Please let us know what you think of our products and services.

Give Feedback

Information

Visit our dedicated information section to learn more about MDPI.

Get Information

Open AccessArticle

Article Versions Notes

Int. J. Mol. Sci. 2016, 17(11), 1879; https://doi.org/10.3390/ijms17111879

Action	Date	Notes	Link
article pdf uploaded.	10 November 2016 12:13 CET	Version of Record	https://www.mdpi.com/1422-0067/17/11/1879/pdf
article xml uploaded.	10 November 2016 12:13 CET	Original file	https://www.mdpi.com/1422-0067/17/11/1879/xml
article html file updated	10 November 2016 12:15 CET	Original file	-
article html file updated	2 December 2016 02:43 CET	Update	-
article html file updated	4 May 2019 22:52 CEST	Update	-
article html file updated	7 February 2020 17:49 CET	Update	https://www.mdpi.com/1422-0067/17/11/1879/html

Cite

Export citation file: BibTeX | EndNote | RIS

MDPI and ACS Style

Ecke, T.H.; Huang-Tiel, H.-J.; Golka, K.; Selinski, S.; Geis, B.C.; Koswig, S.; Bathe, K.; Hallmann, S.; Gerullis, H. Prostate Specific Antigen (PSA) as Predicting Marker for Clinical Outcome and Evaluation of Early Toxicity Rate after High-Dose Rate Brachytherapy (HDR-BT) in Combination with Additional External Beam Radiation Therapy (EBRT) for High Risk Prostate Cancer. Int. J. Mol. Sci. 2016, 17, 1879. https://doi.org/10.3390/ijms17111879

AMA Style

Ecke TH, Huang-Tiel H-J, Golka K, Selinski S, Geis BC, Koswig S, Bathe K, Hallmann S, Gerullis H. Prostate Specific Antigen (PSA) as Predicting Marker for Clinical Outcome and Evaluation of Early Toxicity Rate after High-Dose Rate Brachytherapy (HDR-BT) in Combination with Additional External Beam Radiation Therapy (EBRT) for High Risk Prostate Cancer. International Journal of Molecular Sciences. 2016; 17(11):1879. https://doi.org/10.3390/ijms17111879

Chicago/Turabian Style

Ecke, Thorsten H., Hui-Juan Huang-Tiel, Klaus Golka, Silvia Selinski, Berit Christine Geis, Stephan Koswig, Katrin Bathe, Steffen Hallmann, and Holger Gerullis. 2016. "Prostate Specific Antigen (PSA) as Predicting Marker for Clinical Outcome and Evaluation of Early Toxicity Rate after High-Dose Rate Brachytherapy (HDR-BT) in Combination with Additional External Beam Radiation Therapy (EBRT) for High Risk Prostate Cancer" International Journal of Molecular Sciences 17, no. 11: 1879. https://doi.org/10.3390/ijms17111879

APA Style

Ecke, T. H., Huang-Tiel, H.-J., Golka, K., Selinski, S., Geis, B. C., Koswig, S., Bathe, K., Hallmann, S., & Gerullis, H. (2016). Prostate Specific Antigen (PSA) as Predicting Marker for Clinical Outcome and Evaluation of Early Toxicity Rate after High-Dose Rate Brachytherapy (HDR-BT) in Combination with Additional External Beam Radiation Therapy (EBRT) for High Risk Prostate Cancer. International Journal of Molecular Sciences, 17(11), 1879. https://doi.org/10.3390/ijms17111879

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Statistics

For more information on the journal statistics, click here.

Multiple requests from the same IP address are counted as one view.

Article Menu

Printed Edition

Article Versions Notes

Further Information

Guidelines

MDPI Initiatives

Follow MDPI